<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="24261">Glucocorticoids</z:chebi> have been reported to aggravate ischemic neuronal damage </plain></SENT>
<SENT sid="1" pm="."><plain>Because energy failure is a crucial factor in the development of ischemic neuronal injury, the effects of <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> on histologic outcome and energy metabolism were investigated in gerbil brain </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="41879">Dexamethasone</z:chebi> (3 microg, i.c.v.) was administered 1 h prior to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, and its effect on delayed neuronal <z:hpo ids='HP_0011420'>death</z:hpo> caused by 2 min of bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> was observed in hippocampal CA1 pyramidal neurons </plain></SENT>
<SENT sid="3" pm="."><plain>The brain concentration of ATP after various durations of decapitation <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was determined, and the effect of <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> (3 microg, i.c.v.) was examined </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="1" ids="29101">Na+</z:chebi>,K+-activated <z:chebi fb="3" ids="16335">adenosine</z:chebi> triphosphatase (<z:chebi fb="1" ids="29101">Na+</z:chebi>,K+-ATPase) activity was evaluated after the administration of the agent </plain></SENT>
<SENT sid="5" pm="."><plain>Forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> for 2 min produced neuronal damage in animals pretreated with <z:chebi fb="0" ids="41879">dexamethasone</z:chebi>, although neuronal damage was not observed in vehicle-injected animals </plain></SENT>
<SENT sid="6" pm="."><plain>Decapitation <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> for 0.5 and 1 min reduced the brain ATP concentration to 44% and 15% of the basal level, respectively </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="41879">Dexamethasone</z:chebi> attenuated the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced reduction in ATP, and the values were 58% and 25% of the basal level, respectively </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="1" ids="29101">Na+</z:chebi>,K+-ATPase activity at pH 6.7 was suppressed to 47% by <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> treatment (3 microg, i.c.v.), whereas the activity at pH 7.4 was not influenced by the agent </plain></SENT>
<SENT sid="9" pm="."><plain>The results show that a contributing factor to the aggravation of ischemic neuronal damage may be a disturbance in <z:chebi fb="1" ids="29101">Na+</z:chebi>,K+-ATPase despite adequate levels of ATP </plain></SENT>
</text></document>